Chronotherapeutics for Solid Tumors.

Chronotherapeutics for Solid Tumors.
复制标题

DOI:
10.3390/pharmaceutics15082023
复制
发表时间:
2023-07-26
期刊:
影响因子:
5.4
通讯作者:
Walker II, William H.
Walker II, William H.
中科院分区:
医学2区
文献类型:
--
作者:
Kisamore, Claire O.;Elliott, Brittany D.;Devries, A. Courtney;Nelson, Randy J.;Walker II, William H.

文献摘要

参考文献

相似文献

昼夜节律是24小时太阳日的内部表现,允许生物和行为过程与外部太阳日同步。这种精确的生理和行为调节提高了适应功能和生存能力。时间疗法利用生理过程中的昼夜节律来优化给药时间,以达到最大的治疗效果和最小化的负面副作用。时间疗法在50多年前首次被证明是有益的,并且对不同类型的癌症都有良好的效果。然而,时间疗法在临床上的应用仍然有限。本文综述了时间疗法治疗实体瘤的证据。具体来说,研究检查时间化疗,时间放疗和替代时间治疗(如激素治疗,TKIs,抗血管生成治疗,免疫治疗)进行了讨论。此外,我们提出了需要研究的领域,并确定了该领域有待解决的挑战。
Circadian rhythms are internal manifestations of the 24-h solar day that allow for synchronization of biological and behavioral processes to the external solar day. This precise regulation of physiology and behavior improves adaptive function and survival. Chronotherapy takes advantage of circadian rhythms in physiological processes to optimize the timing of drug administration to achieve maximal therapeutic efficacy and minimize negative side effects. Chronotherapy for cancer treatment was first demonstrated to be beneficial more than five decades ago and has favorable effects across diverse cancer types. However, implementation of chronotherapy in clinic remains limited. The present review examines the evidence for chronotherapeutic treatment for solid tumors. Specifically, studies examining chrono-chemotherapy, chrono-radiotherapy, and alternative chronotherapeutics (e.g., hormone therapy, TKIs, antiangiogenic therapy, immunotherapy) are discussed. In addition, we propose areas of needed research and identify challenges in the field that remain to be addressed.
淋巴细胞昼夜节律的时钟控制淋巴结运输和适应性免疫反应。
DOI: 10.1016/j.immuni.2016.12.011
发表时间: 2017-01-17
期刊: Immunity
影响因子: 32.4
作者:
Druzd D;Matveeva O;Ince L;Harrison U;He W;Schmal C;Herzel H;Tsang AH;Kawakami N;Leliavski A;Uhl O;Yao L;Sander LE;Chen CS;Kraus K;de Juan A;Hergenhan SM;Ehlers M;Koletzko B;Haas R;Solbach W;Oster H;Scheiermann C
通讯作者: Scheiermann C
DOI: 10.3390/cancers14205071
发表时间: 2022-10-17
期刊: Cancers
影响因子: 5.2
作者:
通讯作者: --
DOI: 10.3389/fonc.2021.752331
发表时间: 2021
影响因子: 4.7
作者:
Walker WH 2nd;Sprowls SA;Bumgarner JR;Liu JA;Meléndez-Fernández OH;Walton JC;Lockman PR;DeVries AC;Nelson RJ
通讯作者: Nelson RJ
DOI: 10.1073/pnas.0409897102
发表时间: 2005-03-01
影响因子: 11.1
作者:
Gorbacheva, VY;Kondratov, RV;Antoch, MP
通讯作者: Antoch, MP
DOI: 10.1016/j.molcel.2006.03.038
发表时间: 2006-05-05
期刊: MOLECULAR CELL
影响因子: 16
作者:
Gery, S;Komatsu, N;Koeffler, HP
通讯作者: Koeffler, HP